512 Followers on Owler
BDSI
BDSI is a biotechnology company that researches and commercializes proprietary drugs for the treatment of pain management and addiction.
Read more
CEO
Jeffrey A. Bailey
BDSI TOP COMPETITORS OR ALTERNATIVES
RANK
COMPANY
CEO
CEO RATING
EMPLOYEES
FUNDING
REVENUE
Missing a competitor? Contribute!
Collegium Pharmaceutical is seen as one of BDSI's biggest rivals. Collegium Pharmaceutical is headquartered in Stoughton, Massachusetts, and was founded in 2003. Like BDSI, Collegium Pharmaceutical also works within the Pharmaceuticals sector. Collegium Pharmaceutical generates 198% the revenue of BDSI.
Looking for similar companies to BDSI?
Trending News for BDSI and BDSI's Competitors
September 22, 2021
Benzinga
Why Endo International's Stock Is Trading Higher Today
Endo International plc (NASDAQ:ENDP) shares are trading higher after the company announced the launch... See more »
September 22, 2021
Benzinga
Why Endo International's Stock Is Trading Higher Today
Endo International plc (NASDAQ:ENDP) shares are trading higher after the company announced the launch... See more »
BDSI Quarterly and Annual Revenue
Trailing 12-Months Trend (TTM)
Annual Revenue
$164.1M
BDSI's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 450.7M. Over the last four quarters, BDSI's revenue has grown by 5.1%. Specifically, in Q2 2021's revenue was $41.4M; in Q1 2021, it was $41M; in Q4 2020, it was $42.2M; in Q3 2020, BDSI's revenue was $39.4M.
BDSI Acquisitions
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
These are all the companies that BDSI has acquired. BDSI's latest acquisition was Arius Pharmaceuticals in Aug 2004.
BDSI Funding History
Since BDSI was founded in 1997, it has participated in 8 rounds of funding. In total BDSI has raised $206.2M. BDSI's last funding round was on May 2018 for a total of $50.0M
BDSI Investments
No recent investments found related to BDSI
BDSI News
September 7, 2021Benzinga
BioDelivery Sciences to Exhibit Three Scientific Posters Comparing BELBUCA to Oxycodone at the PAINWeek 2021 Conference
RALEIGH, N.C., Sept. 07, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BD... See more »
August 21, 2021Seeking Alpha
BioDelivery Sciences awarded $24 million contract from Dept. of Veteran Affairs
August 5, 2021India Infoline
Dr Reddy's Lab signs deal with BioDelivery Sciences to sell US and Canada territory rights for EL YXYB
As per the agreement, Dr Reddy's will receive $6 million upfront upon closing followed by $9 million ... See more »
August 4, 2021MarketScreener
Press Release (Form 6-K)
(marketscreener.com) Sub: Press Release Please find enclosed a Press Release on 'Dr. Reddy's Laborato... See more »
August 4, 2021WRAL TechWire
Raleigh pharma firm BDSI paying millions to acquire migraine treatment
BioDelivery Sciences International is paying millions to acquire rights in the U.S. and Canada for an... See more »
August 4, 2021Benzinga
BioDelivery Sciences Reports Mixed Q2 Earnings, Sees FY21 Belbuca Sales At Lower End Of Guidance Range
BioDelivery Sciences International Inc (NASDAQ: BDSI) has reported Q2 sales of $41.4 million, + 13.3%... See more »
April 20, 2021BioSpace
BioDelivery Sciences to Report First Quarter 2021 Financial Results on May 6, 2021
BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical c... See more »
BDSI Press Releases
April 28, 2020GlobeNewswire
BioDelivery Sciences to Report First Quarter 2020 Financial Results on May 7, 2020
RALEIGH, N.C., April 28, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: B... See more »
December 19, 2019GlobeNewswire
BioDelivery Sciences Added to NASDAQ Biotechnology Index
RALEIGH, N.C., Dec. 19, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (Nasdaq: BD... See more »
December 11, 2019StreetInsider
Emmy® and Tony Award® Winning Actress Kristin Chenoweth Introduces 'This Is Pain' Campaign to Improve the Lives of Those Living with Chronic Pain
RALEIGH, N.C., Dec. 11, 2019 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI),... See more »
November 12, 2019GlobeNewswire
BioDelivery Sciences Reports Strong Third Quarter Results, Raises Full Year 2019 and Provides 2020 Net Sales Expectations
BELBUCA® Net Sales Increased by 115% versus Prior Year to All-time High of $26.5 Million... See more »
October 1, 2019GlobeNewswire
BioDelivery Sciences Announces Significant Additional Insurance Coverage for both BELBUCA® and Symproic®
BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company dedicated... See more »
June 24, 2019GlobeNewswire
BioDelivery Sciences Expands Upon Report from Pain Management Task Force
Company's Activities Support Buprenorphine Recommendations Including:... See more »
May 29, 2019GlobeNewswire
BioDelivery Sciences Announces Upcoming Investor Conference Presentations
RALEIGH, N.C., May 29, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDS... See more »
Social Media
BDSI Headquarters
Trending Companies
IN THE NEWS
Food Bazaar | Elliott Management | Sanofi | Nextlink Internet | StarStone | molzi | Intel | Roper Technologies | Turquoise Hill | Constellation Brands | Mastercard | Lipocine | Seattle Genetics | Reliable Robotics Corporation | Simon | Spotlight Brands | General Dynamics | Malibu Boats | ICE | EnLink | Ecolab | T-Mobile | FAR Resources | AIA Chicago | Johnson & Johnson | Pioneer Natural Resources | Fashionphile | VRR | Virtu Financial | Gilead | Northland Rehab Supply | Edwards | Xaar | PayPal | Molson Coors | Cummins | 500 | WPX Energy | McDonald's | Zogenix | Medifast | Quest Diagnostics | Winston Gold Mining | Telford Homes | Costa | Avient Distribution | Entergy | Capitan Mining | Alan Ward | POCO
PEOPLE ALSO VIEWED
Capricor | MAKScientific | Econotech | Us Medical Innovations | Viela Bio | InterMune | Fulgent Genetics | Aries Agro | Hµrel | Corcept | Geneseeq | Edico Genome | MindMed | Biotie Therapies Corp. | Hanmi Pharm | Joinovernight | ITT Engineered Valves | CORDENTAL Group | Identify3d | TTLLP | Adlai Nortye | Vistatubes | Maxwellia | Slate Bio | Mrd Lifesciences, Lucknow | Zubie, CO | EpiEP | Wibisco | Tatneft | Inca Kola
BDSI Summary
ABOUT
Overview
BDSI is a biotechnology company that researches and commercializes proprietary drugs for the treatment of pain management and addiction. BDSI was founded in 1997. BDSI's headquarters is located in Raleigh, North Carolina, USA 27612. It has raised 206....CEO
BDSI's CEO, Jeffrey A. Bailey, currently has an approval rating of 89%. BDSI's primary competitors are Collegium Pharmaceutical, Zyla Life Sciences & Flexion Therapeutics.Website
bdsi.comFrequently Asked Questions about BDSI
When was BDSI founded?
BDSI was founded in 1997Who is BDSI's CEO?
BDSI's CEO is Jeffrey A. BaileyHow much revenue does BDSI generate?
BDSI generates $164.1M in revenueHow much funding does BDSI have?
BDSI has historically raised $206.2M in funding
Where is BDSI's headquarters?
BDSI's headquarters is in Raleigh North Carolina, USAHow many employees does BDSI have?
BDSI has 164 employeesWhat sector does BDSI operate in?
BDSI is in PharmaceuticalsWho are BDSI's competitors?
BDSI's top competitors are Collegium Pharmaceutical, Zyla Life Sciences, Flexion Therapeutics